Contribution of Therapeutic Monitoring in the Assessment of Toxic Adverse Effects of Mitotane: a Case Report
- Authors
- Type
- Published Article
- Journal
- Thérapie
- Publisher
- Elsevier
- Publication Date
- Aug 04, 2015
- Volume
- 70
- Issue
- 6
- Pages
- 545–546
- Identifiers
- DOI: 10.2515/therapie/2015043
- Source
- EDP Sciences
- Keywords
- License
- White
Abstract
Mitotane provided serious side effects and low doses seemed to be tolerated. Determination of mitotane concentration in plasma is recommended. We report the case of toxic plasma levels with low doses of mitotane in a 47-year-old man with adrenocortical cancer.
